Can an early, tailored return to work management intervention focused on support to cancer patients undergoing treatment and their workplaces enhance the readiness for return to work and the return to work rate?

In a controlled clinical trial it is studied if occupational rehabilitation of cancer patients initiated parallel to cancer treatment at the hospital enhances the readiness for return to work and the return to work rate?

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN50753764

Enrollment

430

Registered

2014-08-21

Start date

2013-12-06

Completion date

Unknown

Last updated

2021-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eligible patients are newly diagnosed with breast, gastro-intestinal, head and neck, testis, ovarian or cervix cancer, and are referred to chemotherapy or radiotherapy. Cancer

Interventions

Intervention The intervention is a new way of conducting municipal occupational rehabilitation. The intervention aims at supporting and helping cancer patients to retur

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. 18-60 years of age 2. Place of residence: Silkeborg Municipality or Randers Municipality 3. Participants are permanent or temporary employed (with at least 6 months left by the time of inclusion) and possibly sick-listed at the start of the intervention. 4. Patients diagnosed with breast, gastro-intestinal, head and neck, testis, ovarian or cervix cancer. 5. Patients referred to chemotherapy or radiotherapy in the oncology ward at the Aarhus University Hospital. The control patients have identical inclusion criteria except for place of residence.

Exclusion criteria

Exclusion criteria: Patients who cannot speak or read Danish.

Design outcomes

Primary

Measure	Time frame
The primary outcome is RTW rates among cancer survivors in the intervention group compared with the control group. Return to work is defined by at least 4 consecutive weeks of no social transfer payments or attending a modified job called flexi job. The outcome is identified in a national register on weekly public transfer payments called the DREAM-register. Four consecutive weeks of no transfer payment is considered to be equivalent to RTW along with four consecutive weeks of transfer payment equivalent to attending in a flexi job.	—

Measure

Time frame

The primary outcome is RTW rates among cancer survivors in the intervention group compared with the control group. Return to work is defined by at least 4 consecutive weeks of no social transfer payments or attending a modified job called flexi job. The outcome is identified in a national register on weekly public transfer payments called the DREAM-register. Four consecutive weeks of no transfer payment is considered to be equivalent to RTW along with four consecutive weeks of transfer payment equivalent to attending in a flexi job.

—

Secondary

Measure	Time frame
The secondary outcomes are whether socioeconomic status or co-morbidity is modifying the effect of the intervention on RTW. Socioeconomic status is defined by marital status, having children, educational level, employment status, last year income, work position, whether being in a management position, whether ones housing is owned, and ethnicity. The information is identified in Statistics Denmark. Co-morbidity is defined by the Charlson-index and identified in the medical records at Aarhus University Hospital.	—

Measure

Time frame

The secondary outcomes are whether socioeconomic status or co-morbidity is modifying the effect of the intervention on RTW. Socioeconomic status is defined by marital status, having children, educational level, employment status, last year income, work position, whether being in a management position, whether ones housing is owned, and ethnicity. The information is identified in Statistics Denmark. Co-morbidity is defined by the Charlson-index and identified in the medical records at Aarhus University Hospital.

—

Countries

Denmark

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 4, 2026